Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VolitionRX Ltd VNRX

Healthcare Medical Instruments & Supplies
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and... see more

Recent & Breaking News (NYSEAM:VNRX)

Heska Corporation Signs Exclusive Agreement to Introduce Nu.Q® Vet Cancer Screening Test, First-Ever Point of Care Cancer Screen

PR Newswire March 29, 2022

VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update

PR Newswire March 28, 2022

Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas

PR Newswire January 20, 2022

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

PR Newswire December 16, 2021

VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update

PR Newswire November 10, 2021

VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update

PR Newswire November 8, 2021

Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference

PR Newswire November 4, 2021

VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update

PR Newswire August 11, 2021

VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update

PR Newswire August 4, 2021

Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring

PR Newswire July 22, 2021

Sidoti Summer Virtual Small-Cap Conference

Accesswire June 22, 2021

Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021

GlobeNewswire June 21, 2021

VolitionRx Limited to Webcast Live at Life Sciences Investor Forum June 24th

GlobeNewswire June 21, 2021

Sidoti Microcap Virtual Conference

Accesswire May 18, 2021

VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update

PR Newswire May 11, 2021

VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update

PR Newswire May 6, 2021

Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

Accesswire April 19, 2021

VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper

PR Newswire March 31, 2021

VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary

PR Newswire March 30, 2021

VolitionRx Limited Appoints Two New Directors

PR Newswire March 29, 2021